LEAP2 and obesity disorder: In terms of the biological actions, in 2019, Mani and colleagues revealed that plasma level of LEAP-2 fluctuated in opposite to that of ghrelin according to metabolic status, and was positively correlated with body mass index (BMI) and many metabolic parameters of obesity (10).